Multiple Systemic Infectious Disease Syndrome
For over 30 years I have been working with functional medicine and have encountering many aliments, offering my clients a number of healing modalities. With its co-infections and divergent viruses, the one that stands out as being one of the most challenging to address is Lyme Disease.
Since I have experienced Lyme Disease firsthand, I understand the anxiety of seeing different Medical Doctors and not finding relief. Considering that I have a PhD in Psychotherapy, it was especially frustrating to be told that it was “all in my head”. Having many symptoms and not finding answers served as impetus for me to develop therapies that worked for myself and my clients.
What makes Lyme Disease so difficult to identity? The Lyme Spirochete can cause infection within multiple organs. It often masquerades as other ailments, presenting with a wide range of symptoms that are currently categorized as:
- Rheumatologic Conditions
- Neurologic Conditions
- Chronic Fatigue Syndrome
- Somatization Disorder
- Multiple Sclerosis (MS) spectrum symptoms
- Other difficult-to-diagnose multi-system illnesses
As if all of this is not challenging enough, Lyme Disease is no longer just from the Deer Tick; Fleas, other Ticks, Mosquitoes and Black Flies can all carry it along with a host of other ailments. Below is information that outlines the tools that we use to assess via testing methodologies and the Scoring Tool, Horowitz Lyme - MSIDS Questionnaire (used with permission from Dr. Richard Horowitz). Then we can find the appropriate therapies for your particular case. To fill out this questionnaire and bring it to our office, go to the Lyme Disease Therapy section of our website: http://www.dralanshair.com/lyme-disease-therapy.
QUESTIONS THAT WE ASK OUR CLIENTS - ENVIRONMENTAL HISTORY
Where do they reside? Were they near the woods? Were there deer around? Were they near water?
Does the patient walk, hike or hunt? Do they participate in any other sports, where they would be
in the woods? Does the patient like to walk on grass bare-footed?
A LIST OF BACTERIA
Numerous different Borrelia, Ehrlichia, Bartonella, Babesia, Anaplasma, Q-fever, Typhus, RMSF, Tularemia, FL- 1953 (Protomyxoa rheumatic), Parasites: Filiariasis; and more.
Viruses: TBE, Powassan (POW) Bourbon Viruses, and the list goes on.
LAB AND OTHER TESTING METHODOLOGIES
iSpot Lyme Test
BIO-FEEDBACK ENERGETICS ON ACUPUNCTURE MERIDIAN POINT TESTING
- These are acupuncture meridians that have been used for thousands of years by Traditional Eastern Medicine.
- These meridians are being used in relationship to the energy of specific glands or organs.
This is a useful tool to deploy in conjunction with the different therapies.
APPROACH OF THE THERAPY
There are numerous Borrellia bacteria and co-infections involved, so the patient's immune system must be addressed and supported appropriately:
- Homeopathic Remedies, Sarcodes, Nosodes and also Isopathic Biologic Medicines, which help balance the body, in order to cultivate an environment impossible for pathogens to exist.
- Herbs that have anti-pathogenic properties which work together with the aforementioned, Homeopathic Remedies, for a synergistic approach.
- Gene Testing: If these genes are not present, the ability to detoxify some toxic compounds
may be reduced.
- GSTM1: This gene is associated with the body’s ability to detoxify metals and various toxins, which may affect the toxicity, and efficacy of some drugs. GSTM1 is not present in about
40% of the population.
- GSTP1: This gene code is for the enzyme that supports the detoxification of carcinogens,
drugs, environmental pollutants, food additives, hydrocarbons, and pesticides.
MULTIPLE DRUG RESISTANCE
MDR1: The MDR1 gene provides coding for p-glycoprotein, which protects cells against environmental toxins (xenobiotics), drugs, steroids, and cytokines, by transporting them across extra-cellular and intra-cellular membranes, including the blood-brain-barrier (BBB). In addition, the MDR1 gene is involved in phase III detoxification, by removing harmful substances from the cell. Hereditary variations in this gene may increase the risk for the penetration, or transport, of xenobiotics, drugs, steroids and cytokines into or out of cells, and across the BBB.